12
Total deals
$3.7B
Total value
$407.2M
Avg deal
$1.3B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
ImCheck Therapeutics
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the t…
|
2025-10-22 | Acquisition | Complete | $406.3M | Deal → |
| 2 |
Albireo Pharma
Albireo Pharma a biotechnology company develops therapeutic drugs for gastrointe…
|
2023-01-09 | Merge | Complete | $952.0M | Deal → |
| 3 |
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer a…
|
2022-06-27 | Acquisition | Complete | $247.0M | Deal → |
| 4 |
Clementia Pharmaceuticals
Clementia is a clinical-stage company innovating treatments for people with ultr…
|
2019-02-25 | Acquisition | Complete | $1.3B | Deal → |
| 5 |
Merrimack
Merrimack is a biopharmaceutical company that designs and develops medicines to …
|
2017-04-03 | Acquisition | Complete | — | Deal → |
| 6 |
OctreoPharm Sciences
OctreoPharm Sciences is focused on the development of new radio pharmaceuticals …
|
2015-06-30 | Acquisition | Complete | $55.7M | Deal → |
| 7 |
Canbex Therapeutics
Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (M…
|
2015-02-27 | Acquisition | Complete | $107.5M | Deal → |
| 8 |
Syntaxin
Syntaxin engineers and develops bacterial-based protein therapeutics for the tre…
|
2013-07-15 | Acquisition | Complete | $206.0M | Deal → |
| 9 |
I
Ipsen Pharmaceuticals, Inc.
Ipsen Pharmaceuticals, Inc. provides pharmaceutical products.
|
2008-07-05 | Acquisition | Complete | $17.5M | Deal → |
| 10 |
O
Octagen
Octagen Corporation, a biopharmaceutical company, engages in the discovery, deve…
|
2008-06-05 | Acquisition | Complete | — | Deal → |
| 11 |
Tercica
Tercica, a biotechnology company, develops and commercializes therapeutics for t…
|
2008-06-04 | Acquisition | Complete | $373.0M | Deal → |
| 12 |
S
Sterix Ltd.
Sterix Ltd operates as a biopharmaceutical company that provides research and de…
|
2004-03-04 | Acquisition | Complete | — | Deal → |